rs11467497
Positions:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_030931.4(DEFB126):βc.163_166delβ(p.Gln55GlyfsTer28) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.155 in 1,613,660 control chromosomes in the GnomAD database, including 20,495 homozygotes. Variant has been reported in ClinVar as Benign (β ).
Frequency
Genomes: π 0.18 ( 2602 hom., cov: 28)
Exomes π: 0.15 ( 17893 hom. )
Consequence
DEFB126
NM_030931.4 frameshift
NM_030931.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.332
Genes affected
DEFB126 (HGNC:15900): (defensin beta 126) Defensins are cysteine-rich cationic polypeptides that are important in the immunologic response to invading microorganisms. The antimicrobial protein encoded by this gene is secreted and is a member of the beta defensin protein family. Beta defensin genes are found in several clusters throughout the genome, with this gene mapping to a cluster at 20p13. The encoded protein is highly similar to an epididymal-specific secretory protein (ESP13.2) from cynomolgus monkey. Mutation of this gene is associated with impaired sperm function. [provided by RefSeq, Nov 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 20-145514-GCAAA-G is Benign according to our data. Variant chr20-145514-GCAAA-G is described in ClinVar as [Benign]. Clinvar id is 402585.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.256 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DEFB126 | NM_030931.4 | c.163_166del | p.Gln55GlyfsTer28 | frameshift_variant | 2/2 | ENST00000382398.4 | NP_112193.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DEFB126 | ENST00000382398.4 | c.163_166del | p.Gln55GlyfsTer28 | frameshift_variant | 2/2 | 1 | NM_030931.4 | ENSP00000371835 | P1 | |
DEFB126 | ENST00000542572.1 | n.127+31_127+34del | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.178 AC: 27075AN: 151918Hom.: 2594 Cov.: 28
GnomAD3 genomes
AF:
AC:
27075
AN:
151918
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.146 AC: 36734AN: 251278Hom.: 3023 AF XY: 0.148 AC XY: 20148AN XY: 135806
GnomAD3 exomes
AF:
AC:
36734
AN:
251278
Hom.:
AF XY:
AC XY:
20148
AN XY:
135806
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.153 AC: 223011AN: 1461624Hom.: 17893 AF XY: 0.153 AC XY: 111356AN XY: 727118
GnomAD4 exome
AF:
AC:
223011
AN:
1461624
Hom.:
AF XY:
AC XY:
111356
AN XY:
727118
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.178 AC: 27102AN: 152036Hom.: 2602 Cov.: 28 AF XY: 0.174 AC XY: 12925AN XY: 74330
GnomAD4 genome
AF:
AC:
27102
AN:
152036
Hom.:
Cov.:
28
AF XY:
AC XY:
12925
AN XY:
74330
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
487
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in ESP (all): 2401/12518=19.1% - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at